CompletedPhase 4NCT01039285
Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Jean Michel Hascoet
- Principal Investigator
- Jean-Michel HASCOET, MDMaternite Regionale Universitaire NANCY
- Intervention
- Curosurf(drug)
- Enrollment
- 118 enrolled
- Eligibility
- All sexes
- Timeline
- 2009 – 2022
Study locations (13)
- CHU Hopital Nord, Amiens, France
- CHU, Angers, France
- Centre Hospitalier, Arras, France
- CHU Hopital Clemenceau, Caen, France
- CHU hopital d'enfants, Dijon, France
- Centre Hospitalier, Lens, France
- CHU Hopital Jeanne de Flandre, Lille, France
- CHU Hopital de la Croix Rousse, Lyon, France
- APHM hopital de la conception, Marseille, France
- CHI Andre Gregoire, Montreuil, France
- Maternite Regionale Universitaire, Nancy, France
- AP-HP Hopital Port Royal, Paris, France
- CHU Hopital Gatien de Clocheville, Tours, France
Collaborators
ARAIRLOR · Chiesi Farmaceutici S.p.A.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01039285 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGPHASE1NCT06589245Inhaled Ciclesonide Study in Preterm InfantsVenkatesh Sampath